EN
HI
Shukra Pharmaceuticals Chart
Shukra Pharmaceuticals Share Key Metrics
Volume
75812.00
Market Cap
1396.40 CR
LTQ@LTP
545@32.08
ATP
31.73
Var Margin
100 %
Circuit Range
30.3-33.48
Delivery %
56.83 %
Value
24.06 L
ASM/GSM
No
Market Lot
1
Summary
At 6 Apr, 2026 | 11:56, Shukra Pharmaceuticals share price stands at ₹32.08, showing a 0.19% 0.60 for the day. The stock’s intraday movement has stayed between ₹31.00 and ₹33.19, while on a 52-week basis it has fluctuated from ₹11.74 to ₹65.26.
In terms of trading activity, Shukra Pharmaceuticals has recorded a volume of 75812 shares, with a market capitalisation of ₹437879440. The stock’s Average Traded Price (ATP) stands at ₹3173, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 545,3208. The stock operates within a circuit range of ₹30.3-33.48, with a Value of ₹24.06 L. The Delivery Percentage for the day is 56.83%. Additionally, Shukra Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.
Shukra Pharmaceuticals Fundamentals
View MoreP/E Ratio
0
P/B Ratio
0
Div. Yield
0.03
Sector P/E
60.59
Sector P/B
3.25
Sec. Div. Yield
0.59
Shukra Pharmaceuticals Resistance and Support
Pivot 31.65
Resistance
First Resistance
33.04
Second Resistance
34.19
Third Resistance
35.58
Support
First Support
30.5
Second Support
29.11
Third Support
27.96
Shukra Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-03-16 | Others |
| 2026-02-04 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-10-03 | Others |
| 2025-08-13 | Quarterly Results |
| 2025-06-04 | Final Dividend |
| 2025-05-29 | Audited Results |
| 2025-02-14 | Quarterly Results |
| 2025-01-29 | Stock Split |
| 2025-01-09 | Others |
Shukra Pharmaceuticals News
About Shukra Pharmaceuticals
NSE : 0
BSE : 524632
ISIN : INE551C01044
Shukra Pharmaceuticals Management
| Name | Position |
|---|---|
| Mr. Dakshesh Rameshchandra Shah | Managing Director |
| Mrs. Payal Sujay Mehta | Executive Director |
Shukra Pharmaceuticals Similar Stocks
Shamrock Industrial Company Ltd.
21.38
0.00 (0.00%)
Fabino Enterprises Ltd.
16.73
0.00 (0.00%)
Cresanto Global Ltd.
0.00
0.00 (0.00%)
Cian Healthcare Ltd.
0.00
0.00 (0.00%)
Gujarat Terce Laboratories Ltd.
31.33
-0.63 (1.97%)
Ortin Global Ltd.
13.73
0.00 (0.00%)
Solara Active Pharma Sciences Ltd. - (Partly Paid-up Equity Shares (Rights Issue))
308.70
0.00 (0.00%)
Kretto Syscon Ltd. - (Rights Entitlements (REs))
0.07
0.00 (0.00%)
Shukra Pharmaceuticals FAQs
The Buying Price of Shukra Pharmaceuticals share is 32.08 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Shukra Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Shukra Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Shukra Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Shukra Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.
To assess Shukra Pharmaceuticals’s valuation compare Sector P/E, P/B which are 60.59 & 3.25 with sector averages, along with growth rates and financial metrics.
The Market Cap of Shukra Pharmaceuticals is 1396.40 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Shukra Pharmaceuticals share price is 65.26 & 11.74. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Shukra Pharmaceuticals belongs to the Healthcare sector.
